LIP
DXCM icon

Liontrust Investment Partners’s DexCom DXCM Stock Holding History

Liontrust Investment Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-103,959
Closed -$9.07M – 195
2025
Q2 		$9.07M Buy
103,959
+3,700
+4% +$290K 0.13% 107
2025
Q1 		$6.85M Buy
100,259
+2,812
+3% +$229K 0.11% 113
2024
Q4 		$7.58M Sell
97,447
-19,641
-17% -$1.45M 0.11% 109
2024
Q3 		$13.3M Hold
117,088
– – 0.19% 84
2024
Q2 		$13.3M Buy
+117,088
New +$14.8M 0.19% 84

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Liontrust Investment Partners's DXCM Position: Q3 2025 in Review

Liontrust Investment Partners sold out of DexCom (DXCM) in Q3 2025, closing a stake of 103,959 shares — an estimated $9.07M sold.

Liontrust Investment Partners first reported a position in DXCM in Q2 2024 and held it in 5 quarters. The position peaked at $13.3M in Q3 2024. 910 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Liontrust Investment Partners reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • Liontrust Investment Partners sold 103,959 DexCom shares in Q3 2025, an estimated $9.07M.
  • Liontrust Investment Partners first reported a position in DexCom in Q2 2024 and held it in 5 quarters.
  • Liontrust Investment Partners's DexCom position peaked at $13.3M in Q3 2024.
  • 910 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Liontrust Investment Partners's 13F filing for Q3 2025, filed 24 Nov 2025.